Thus, immunodetection of the C terminus of the TFE3 protein in ASPS was considered a diagnostic landmark, but it should be interpreted carefully since the list of tumors with TFE3 immunopositivity is increasing. This evidence concerns the gene TFE3 and alveolar soft part sarcoma.